معرفی
Prof. Klaas Nico Faber is a Professor of Experimental Hepatology and Gastroenterology at the University of Groningen, affiliated with the University Medical Center Groningen (UMCG). He leads research at the Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI). His work focuses on liver fibrosis, inflammatory bowel disease (IBD), microbiome interactions, and organoid models. He has authored over 224 publications, including studies on Vedolizumab treatment in allograft enteropathy and the role of microbial metabolism in colonic health. His research contributes to UN Sustainable Development Goals related to health and well-being.
Research interests include the pathophysiology of IBD, liver disease mechanisms, and translational therapies. Notable projects investigate microbial influences on gut health, fibrosis pathways, and biomarker development. Collaborations span global institutions, reflecting his expertise in gastrointestinal genetics and immunology.
Recent articles highlight breakthroughs in microbiome genomics, fibrogenesis modeling, and therapeutic targets for IBD. Awards and recognitions are not explicitly listed, but his extensive peer-reviewed output underscores his academic impact. He supervises research in experimental gastroenterology and mentors teams at 3GI.
